Efficacy and adverse events of immune checkpoint inhibitors: evidence from non-small cell lung cancer and gastric cancer in Korea and Japan
In recent years, immune checkpoint inhibitors (ICIs) have changed the landscape of cancer treatment by harnessing their efficacy in treating malignancies. These cancer therapies have shown remarkable result and efficacy across multiple cancer types. However, this review specifically focuses on non-s...
Saved in:
| Main Authors: | Mc Neil Valencia, Zeeshan Abbas, Seung Won Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sungkyunkwan University School of Medi
2025-03-01
|
| Series: | Precision and Future Medicine |
| Subjects: | |
| Online Access: | http://pfmjournal.org/upload/pdf/pfm-2025-00009.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of immune-related adverse events on the outcome of advanced gastric cancer patients with immune checkpoint inhibitor treatment
by: Tianhang Zhang, et al.
Published: (2024-12-01) -
Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment
by: Hongfang Ma, et al.
Published: (2025-05-01) -
Novel Composite Scoring System for Predicting Prognosis in Stage IV Gastric Cancer Patients Treated with Immune Checkpoint Inhibitors
by: Yang L, et al.
Published: (2025-05-01) -
Establishment of an animal model of immune‐related adverse events induced by immune checkpoint inhibitors
by: Yuan Meng, et al.
Published: (2024-07-01) -
Cardiac Adverse Events in Patients Receiving Immune Checkpoint Inhibitors in the Adjuvant Setting: An FDA Pooled Analysis
by: Asma Dilawari, et al.
Published: (2025-05-01)